Hikma Pharmaceuticals Aktie
17,90
EUR
±0,00
EUR
±0,00
%
16,17
CHF
+0,07
CHF
+0,45
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
| 14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
| 15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
| 10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
| 21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung